Standard

Helium-rich mixtures for improved batch-mode clinical-scale spin-exchange optical pumping of Xenon-129. / Birchall, Jonathan R.; Nikolaou, Panayiotis; Irwin, Robert K. et al.

In: Journal of Magnetic Resonance, Vol. 315, 106739, 06.2020, p. 106739.

Research output: Contribution to journalArticlepeer-review

Harvard

Birchall, JR, Nikolaou, P, Irwin, RK, Barlow, MJ, Ranta, K, Coffey, AM, Goodson, BM, Pokochueva, EV, Kovtunov, KV, Koptyug, IV & Chekmenev, EY 2020, 'Helium-rich mixtures for improved batch-mode clinical-scale spin-exchange optical pumping of Xenon-129', Journal of Magnetic Resonance, vol. 315, 106739, pp. 106739. https://doi.org/10.1016/j.jmr.2020.106739

APA

Birchall, J. R., Nikolaou, P., Irwin, R. K., Barlow, M. J., Ranta, K., Coffey, A. M., Goodson, B. M., Pokochueva, E. V., Kovtunov, K. V., Koptyug, I. V., & Chekmenev, E. Y. (2020). Helium-rich mixtures for improved batch-mode clinical-scale spin-exchange optical pumping of Xenon-129. Journal of Magnetic Resonance, 315, 106739. [106739]. https://doi.org/10.1016/j.jmr.2020.106739

Vancouver

Birchall JR, Nikolaou P, Irwin RK, Barlow MJ, Ranta K, Coffey AM et al. Helium-rich mixtures for improved batch-mode clinical-scale spin-exchange optical pumping of Xenon-129. Journal of Magnetic Resonance. 2020 Jun;315:106739. 106739. Epub 2020 Apr 30. doi: 10.1016/j.jmr.2020.106739

Author

Birchall, Jonathan R. ; Nikolaou, Panayiotis ; Irwin, Robert K. et al. / Helium-rich mixtures for improved batch-mode clinical-scale spin-exchange optical pumping of Xenon-129. In: Journal of Magnetic Resonance. 2020 ; Vol. 315. pp. 106739.

BibTeX

@article{9fa47f17801b485c926fef0422126944,
title = "Helium-rich mixtures for improved batch-mode clinical-scale spin-exchange optical pumping of Xenon-129",
abstract = "We present studies of spin-exchange optical pumping (SEOP) using ternary xenon-nitrogen-helium gas mixtures at high xenon partial pressures (up to 1330 Torr partial pressure at loading, out of 2660 Torr total pressure) in a 500-mL volume SEOP cell, using two automated batch-mode clinical-scale 129Xe hyperpolarizers operating under continuous high-power (~170 W) pump laser irradiation. In this pilot study, we explore SEOP in gas mixtures with up to 45% 4He content under a wide range of experimental conditions. When an aluminum jacket cooling/heating design was employed (GEN-3 hyperpolarizer), 129Xe polarization (%PXe) of 55.9 ± 0.9% was observed with mono-exponential build-up rate γSEOP of 0.049 ± 0.001 min−1 for the 4He-rich mixture (1000 Torr Xe/900 Torr He, 100 Torr N2), compared to %PXe of 49.3 ± 3.3% at γSEOP of 0.035 ± 0.004 min−1 for the N2-rich gas mixture (1000 Torr Xe/100 Torr He, 900 Torr N2). When forced-air cooling/heating was used (GEN-2 hyperpolarizer), %PXe of 83.9 ± 2.7% was observed at γSEOP of 0.045 ± 0.005 min−1 for the 4He-rich mixture (1000 Torr Xe/900 Torr He, 100 Torr N2), compared to %PXe of 73.5 ± 1.3% at γSEOP of 0.028 ± 0.001 min−1 for the N2-rich gas mixture (1000 Torr Xe and 1000 Torr N2). Additionally, %PXe of 72.6 ± 1.4% was observed at a build-up rate γSEOP of 0.041 ± 0.003 min−1 for a super-high-density 4He-rich mixture (1330 Torr Xe/1200 Torr 4He/130 Torr N2), compared to %PXe = 56.6 ± 1.3% at a build-up rate of γSEOP of 0.034 ± 0.002 min−1 for an N2-rich mixture (1330 Torr Xe/1330 Torr N2) using forced air cooling/heating. The observed SEOP hyperpolarization performance under these conditions corresponds to %PXe improvement by a factor of 1.14 ± 0.04 at 1000 Torr Xe density and by up to a factor of 1.28 ± 0.04 at 1330 Torr Xe density at improved SEOP build-up rates by factors of 1.61 ± 0.18 and 1.21 ± 0.11 respectively. Record %PXe levels have been obtained here: 83.9 ± 2.7% at 1000 Torr Xe partial pressure and 72.6 ± 1.4% at 1330 Torr Xe partial pressure. In addition to improved thermal stability for SEOP, the use of 4He-rich gas mixtures also reduces the overall density of produced inhalable HP contrast agents; this property may be desirable for HP 129Xe inhalation by human subjects in clinical settings—especially in populations with heavily impaired lung function. The described approach should enjoy ready application in the production of inhalable 129Xe contrast agent with near-unity 129Xe nuclear spin polarization.",
keywords = "Batch-mode hyperpolarizer, Hyperpolarization, Spin exchange optical pumping, Xenon-129, CELLS, HE-3, POLARIZED XE-129, RB, NMR, TOLERABILITY, MAGNETIC-RESONANCE, HYPERPOLARIZED XE-129, GAS, HEALTHY-VOLUNTEERS",
author = "Birchall, {Jonathan R.} and Panayiotis Nikolaou and Irwin, {Robert K.} and Barlow, {Michael J.} and Kaili Ranta and Coffey, {Aaron M.} and Goodson, {Boyd M.} and Pokochueva, {Ekaterina V.} and Kovtunov, {Kirill V.} and Koptyug, {Igor V.} and Chekmenev, {Eduard Y.}",
note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = jun,
doi = "10.1016/j.jmr.2020.106739",
language = "English",
volume = "315",
pages = "106739",
journal = "Journal of Magnetic Resonance",
issn = "1090-7807",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Helium-rich mixtures for improved batch-mode clinical-scale spin-exchange optical pumping of Xenon-129

AU - Birchall, Jonathan R.

AU - Nikolaou, Panayiotis

AU - Irwin, Robert K.

AU - Barlow, Michael J.

AU - Ranta, Kaili

AU - Coffey, Aaron M.

AU - Goodson, Boyd M.

AU - Pokochueva, Ekaterina V.

AU - Kovtunov, Kirill V.

AU - Koptyug, Igor V.

AU - Chekmenev, Eduard Y.

N1 - Publisher Copyright: © 2020 Elsevier Inc. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/6

Y1 - 2020/6

N2 - We present studies of spin-exchange optical pumping (SEOP) using ternary xenon-nitrogen-helium gas mixtures at high xenon partial pressures (up to 1330 Torr partial pressure at loading, out of 2660 Torr total pressure) in a 500-mL volume SEOP cell, using two automated batch-mode clinical-scale 129Xe hyperpolarizers operating under continuous high-power (~170 W) pump laser irradiation. In this pilot study, we explore SEOP in gas mixtures with up to 45% 4He content under a wide range of experimental conditions. When an aluminum jacket cooling/heating design was employed (GEN-3 hyperpolarizer), 129Xe polarization (%PXe) of 55.9 ± 0.9% was observed with mono-exponential build-up rate γSEOP of 0.049 ± 0.001 min−1 for the 4He-rich mixture (1000 Torr Xe/900 Torr He, 100 Torr N2), compared to %PXe of 49.3 ± 3.3% at γSEOP of 0.035 ± 0.004 min−1 for the N2-rich gas mixture (1000 Torr Xe/100 Torr He, 900 Torr N2). When forced-air cooling/heating was used (GEN-2 hyperpolarizer), %PXe of 83.9 ± 2.7% was observed at γSEOP of 0.045 ± 0.005 min−1 for the 4He-rich mixture (1000 Torr Xe/900 Torr He, 100 Torr N2), compared to %PXe of 73.5 ± 1.3% at γSEOP of 0.028 ± 0.001 min−1 for the N2-rich gas mixture (1000 Torr Xe and 1000 Torr N2). Additionally, %PXe of 72.6 ± 1.4% was observed at a build-up rate γSEOP of 0.041 ± 0.003 min−1 for a super-high-density 4He-rich mixture (1330 Torr Xe/1200 Torr 4He/130 Torr N2), compared to %PXe = 56.6 ± 1.3% at a build-up rate of γSEOP of 0.034 ± 0.002 min−1 for an N2-rich mixture (1330 Torr Xe/1330 Torr N2) using forced air cooling/heating. The observed SEOP hyperpolarization performance under these conditions corresponds to %PXe improvement by a factor of 1.14 ± 0.04 at 1000 Torr Xe density and by up to a factor of 1.28 ± 0.04 at 1330 Torr Xe density at improved SEOP build-up rates by factors of 1.61 ± 0.18 and 1.21 ± 0.11 respectively. Record %PXe levels have been obtained here: 83.9 ± 2.7% at 1000 Torr Xe partial pressure and 72.6 ± 1.4% at 1330 Torr Xe partial pressure. In addition to improved thermal stability for SEOP, the use of 4He-rich gas mixtures also reduces the overall density of produced inhalable HP contrast agents; this property may be desirable for HP 129Xe inhalation by human subjects in clinical settings—especially in populations with heavily impaired lung function. The described approach should enjoy ready application in the production of inhalable 129Xe contrast agent with near-unity 129Xe nuclear spin polarization.

AB - We present studies of spin-exchange optical pumping (SEOP) using ternary xenon-nitrogen-helium gas mixtures at high xenon partial pressures (up to 1330 Torr partial pressure at loading, out of 2660 Torr total pressure) in a 500-mL volume SEOP cell, using two automated batch-mode clinical-scale 129Xe hyperpolarizers operating under continuous high-power (~170 W) pump laser irradiation. In this pilot study, we explore SEOP in gas mixtures with up to 45% 4He content under a wide range of experimental conditions. When an aluminum jacket cooling/heating design was employed (GEN-3 hyperpolarizer), 129Xe polarization (%PXe) of 55.9 ± 0.9% was observed with mono-exponential build-up rate γSEOP of 0.049 ± 0.001 min−1 for the 4He-rich mixture (1000 Torr Xe/900 Torr He, 100 Torr N2), compared to %PXe of 49.3 ± 3.3% at γSEOP of 0.035 ± 0.004 min−1 for the N2-rich gas mixture (1000 Torr Xe/100 Torr He, 900 Torr N2). When forced-air cooling/heating was used (GEN-2 hyperpolarizer), %PXe of 83.9 ± 2.7% was observed at γSEOP of 0.045 ± 0.005 min−1 for the 4He-rich mixture (1000 Torr Xe/900 Torr He, 100 Torr N2), compared to %PXe of 73.5 ± 1.3% at γSEOP of 0.028 ± 0.001 min−1 for the N2-rich gas mixture (1000 Torr Xe and 1000 Torr N2). Additionally, %PXe of 72.6 ± 1.4% was observed at a build-up rate γSEOP of 0.041 ± 0.003 min−1 for a super-high-density 4He-rich mixture (1330 Torr Xe/1200 Torr 4He/130 Torr N2), compared to %PXe = 56.6 ± 1.3% at a build-up rate of γSEOP of 0.034 ± 0.002 min−1 for an N2-rich mixture (1330 Torr Xe/1330 Torr N2) using forced air cooling/heating. The observed SEOP hyperpolarization performance under these conditions corresponds to %PXe improvement by a factor of 1.14 ± 0.04 at 1000 Torr Xe density and by up to a factor of 1.28 ± 0.04 at 1330 Torr Xe density at improved SEOP build-up rates by factors of 1.61 ± 0.18 and 1.21 ± 0.11 respectively. Record %PXe levels have been obtained here: 83.9 ± 2.7% at 1000 Torr Xe partial pressure and 72.6 ± 1.4% at 1330 Torr Xe partial pressure. In addition to improved thermal stability for SEOP, the use of 4He-rich gas mixtures also reduces the overall density of produced inhalable HP contrast agents; this property may be desirable for HP 129Xe inhalation by human subjects in clinical settings—especially in populations with heavily impaired lung function. The described approach should enjoy ready application in the production of inhalable 129Xe contrast agent with near-unity 129Xe nuclear spin polarization.

KW - Batch-mode hyperpolarizer

KW - Hyperpolarization

KW - Spin exchange optical pumping

KW - Xenon-129

KW - CELLS

KW - HE-3

KW - POLARIZED XE-129

KW - RB

KW - NMR

KW - TOLERABILITY

KW - MAGNETIC-RESONANCE

KW - HYPERPOLARIZED XE-129

KW - GAS

KW - HEALTHY-VOLUNTEERS

UR - http://www.scopus.com/inward/record.url?scp=85084336440&partnerID=8YFLogxK

U2 - 10.1016/j.jmr.2020.106739

DO - 10.1016/j.jmr.2020.106739

M3 - Article

C2 - 32408239

AN - SCOPUS:85084336440

VL - 315

SP - 106739

JO - Journal of Magnetic Resonance

JF - Journal of Magnetic Resonance

SN - 1090-7807

M1 - 106739

ER -

ID: 24261919